BE Safe

BE Safe

The follow-up of patients with non-muscle-invasive bladder cancer (NMIBC) is crucial to ensure early detection and prompt treatment of disease recurrence. Under normal circumstances, these patients undergo surveillance cystoscopies every 3 months following diagnosis...